MannKind | Lånekapital



Loan Capital Ändra Datum
Adma Biologics USD 72.34M 28.99M 2024-12
Dynavax Technologies USD 223.85M 293K 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Insmed USD 1.13B 147.77M 2024-12
MacroGenics USD 0 0 2024-12
MannKind USD 267.29M 191.97M 2024-12
Merck USD 34.46B 520M 2024-12
Novo Nordisk DKK 51.45B 156M 2024-09
Pfizer USD 57.4B 597M 2024-12
Sanofi 12.5B 1.84B 2024-06
Xencor USD 115.16M 104.99M 2024-12



MannKind Lånekapital - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.